Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma
For inoperable esophageal adenocarcinoma (EAC), identifying patients likely to benefit from recently approved immunochemotherapy (ICI+CTX) treatments remains a key challenge. We address this using a uniquely designed window-of-opportunity trial (LUD2015-005), in which 35 inoperable EAC patients rece...
मुख्य लेखकों: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
अन्य लेखक: | |
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
Cell Press
2023
|